Cancer results from dysregulation of multiple steps of gene expression programs. We review how transcriptome profiling has been widely explored for cancer classification and biomarker discovery but resulted in limited clinical impact. Therefore, we discuss alternative and complementary omics approaches.
Keywords: cancer; heterogeneity; omics; signatures; transcriptomes.
© The Author 2015. Published by Oxford University Press.